Research News and Research

RSS

AUA Foundation joins AUA in response to the ACS updated prostate cancer screening guidelines

The American Urological Association Foundation joins the AUA in its response to the American Cancer Society updated prostate cancer screening guidelines highlighting the importance of shared decision-making between patients and physicians.

3 Mar 2010

Democrats seem to gain momentum on health reform, but face many obstacles

As Democratic leaders pursue a go-it-alone strategy on health care, the real test will be whether their caucus can pull together and be effective, according to a Politico analysis.

3 Mar 2010

Shock: Norepinephrine favored over dopamine

Physicians treating patients with shock should consider norepinephrine instead of dopamine as a tool for stabilizing blood pressure, according to an editorial in the March 4, 2010, issue of the New England Journal of Medicine (NEJM).

3 Mar 2010

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

CPEX Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of $18.7 million and a net loss of $3.0 million.

3 Mar 2010

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Bristol-Myers Squibb Company and Allergan, Inc. today announced a global agreement for the development and commercialization of AGN-209323, a Phase II-ready, orally administered small molecule in clinical development for neuropathic pain.

3 Mar 2010

Actemra: 38% of rheumatologists have commenced treatment

BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.

3 Mar 2010

Survey underscores need for continued efforts to combat substance abuse among teens

New survey data released today by the Partnership for a Drug-Free America and MetLife Foundation point to the need for continued efforts to combat substance abuse among teens. While there was no significant increase in the abuse of over-the-counter (OTC) cough medicines containing dextromethorphan, the 21st annual Partnership/MetLife Foundation Attitude Tracking Survey (PATS) found an overall waning in teens' negative perceptions about many drugs along with increases in abuse rates for alcohol, ecstasy, and marijuana.

3 Mar 2010

Gene 'addiction' of leukaemia cells

An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.

3 Mar 2010

Allergan celebrates 20th anniversary of BOTOX in Canada

Twenty years ago, the first approved use of BOTOX(R) (botulinum toxin type A), a neurotoxin widely used to treat several life altering medical conditions, was granted in Canada. As part of the 20th anniversary celebrations, healthcare professionals from coast to coast reflect upon the discovery, science and evolution of a therapy that has impacted the lives of millions of patients worldwide.

3 Mar 2010

Shortage of donated blood in the U.S.: Research looks for ways to improve life-saving supply

There is typically a shortage of donated blood in the United States, and research at Case Western Reserve University is looking for ways of improving the life-saving supply.

3 Mar 2010

Seattle Genetics generates $110M through ADC technology license agreements

Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Genentech, Inc., a wholly owned member of the Roche Group.

3 Mar 2010

Blood glucose-lowering hormone FGF21 also activates brown adipose tissue metabolism

The blood glucose-lowering hormone FGF21 is also an activator of brown adipose tissue metabolism, according to the study featured on the cover of Cell Metabolism and directed by the lecturer Francesc Villarroya of the UB's Department of Biochemistry and Molecular Biology (Faculty of Biology), the Institute of Biomedicine, and the Biomedical Research Networking Centre in Physiopathology of Obesity and Nutrition.

3 Mar 2010

Major sports arenas in Europe have no adequate equipment, procedures to save spectators who suffer heart attacks

Too many major sports arenas in Europe do not have adequate equipment and procedures in place to save the lives of spectators who suffer heart attacks while watching a sporting event, according to new research published online today (Wednesday 3 March) in the European Heart Journal.

3 Mar 2010

Mood, behavioral problems after stressful interpersonal events: LPFC function may be a risk-factor

Think back to your last fight with someone you love. How did you feel afterwards? How did you behave? Conflict with a loved one often leaves a person feeling terrible and then behaving badly. So much so that these scenarios have become soap opera clich-s. After an argument, one partner may brood, slam the door, and then drive to a local bar to drown their sorrows in alcohol. These dramas rarely have happy endings. Given these stereotypes, how do people control their emotional reactions and prevent emotional storms and their attendant use of intoxicating substances?

3 Mar 2010

Vaccine researchers at HZI find c-di-IMP molecule, more effective than known adjuvants

The adjuvants present in vaccines have a bad reputation. For most people, they are only unnecessary compounds within a medicinal product. This is a misunderstanding since adjuvants have a critical impact on the success of a vaccination. In the best case scenario, one single vaccination shot would be now sufficient for conferring life-long protection.

3 Mar 2010

First Edition: March 3, 2010

This morning's news is all about President Obama's outreach yesterday to the GOP and his speech today detailing new elements of his health reform plan. Will this step resuscitate the Dem's overhaul efforts?

3 Mar 2010

Concordia University Professor awarded grant to study molecular mechanisms of virulence factor protein

Concordia University is pleased to announce that Dr. Peter D. Pawelek, Assistant Professor, Department of Chemistry and Biochemistry was awarded a grant from the Thalassemia Foundation of Canada to study molecular mechanisms of a virulence factor protein from an opportunistic pathogen that affects thalassemia patients.

3 Mar 2010

UPMC develops its first EHR application for BlackBerry smartphones

In an effort to put critical patient information in the hands of physicians at the bedside, UPMC announced today that it has developed its first electronic health record (EHR) application for BlackBerry® smartphones. The pilot project gives physicians access to such information as a patient’s allergies, current medications and recently completed lab tests.

3 Mar 2010

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

Cellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11.

3 Mar 2010

Report provides comprehensive insight into how physicians classify and treat patients with gout

BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: Gout and Hyperuricemia publication. The report is based on responses to online surveys completed by 120 Rheumatologists and 57 Primary Care Physicians in the US who are managing a high number of patients with gout.

3 Mar 2010

Research News and Research

AUA Foundation joins AUA in response to the ACS updated prostate cancer screening guidelines

Democrats seem to gain momentum on health reform, but face many obstacles

Shock: Norepinephrine favored over dopamine

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Actemra: 38% of rheumatologists have commenced treatment

Survey underscores need for continued efforts to combat substance abuse among teens

Gene 'addiction' of leukaemia cells

Allergan celebrates 20th anniversary of BOTOX in Canada

Shortage of donated blood in the U.S.: Research looks for ways to improve life-saving supply

Seattle Genetics generates $110M through ADC technology license agreements

Blood glucose-lowering hormone FGF21 also activates brown adipose tissue metabolism

Major sports arenas in Europe have no adequate equipment, procedures to save spectators who suffer heart attacks

Mood, behavioral problems after stressful interpersonal events: LPFC function may be a risk-factor

Vaccine researchers at HZI find c-di-IMP molecule, more effective than known adjuvants

First Edition: March 3, 2010

Concordia University Professor awarded grant to study molecular mechanisms of virulence factor protein

UPMC develops its first EHR application for BlackBerry smartphones

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

Report provides comprehensive insight into how physicians classify and treat patients with gout

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence